Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.

Honma, Yoshitaka; Ikeda, Masafumi; Hijioka, Susumu; Matsumoto, Shigemi; Ito, Tetsuhide; Aoki, Taku; Furuse, Junji

Honma, Yoshitaka; Ikeda, Masafumi; Hijioka, Susumu; Matsumoto, Shigemi; Ito, Tetsuhide; Aoki, Taku; Furuse, Junji.

Afiliación

Honma Y; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. yohonma@ncc.go.jp.
Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Hijioka S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Matsumoto S; Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Ito T; Department of Gastroenterology and Hepatology, International University of Health and Welfare Graduate School of Medicine, Neuroendocrine Tumor Centre, Fukuoka Sanno Hospital, 3-6-45 Momochihama, Sawara-ku, Fukuoka, 814-0001, Japan.
Aoki T; Department of Hepato-Biliary-Pancreatic Surgery, Dokkyo Medical University, 800 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
Furuse J; Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa, 214-8515, Japan.

Invest New Drugs ; 41(6): 777-786, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37856005

Asunto(s)

Neoplasias Gastrointestinales; Neoplasias Hepáticas; Tumores Neuroendocrinos; Neoplasias Pancreáticas; Humanos; Tumores Neuroendocrinos/tratamiento farmacológico; Tumores Neuroendocrinos/patología; Octreótido; Everolimus/uso terapéutico; Antígeno Ki-67; Pueblos del Este de Asia; Neoplasias Gastrointestinales/tratamiento farmacológico; Neoplasias Gastrointestinales/patología; Somatostatina/uso terapéutico; Neoplasias Hepáticas/tratamiento farmacológico; Neoplasias Pancreáticas/tratamiento farmacológico

Palabras clave

Everolimus; Gastrointestinal neuroendocrine tumor; Lanreotide; Octreotide; Somatostatin analogue; Systemic therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tumores Neuroendocrinos / Neoplasias Gastrointestinales / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google